目的评价药师干预口服抗肿瘤药物患者用药依从性的成效。方法采用计算机检索PubMed,Web of Science,Embase及中国知网、维普和万方医学数据库中药师对口服抗肿瘤药物患者用药依从性进行干预的相关研究,检索时限为自建库起至2022年4月1...目的评价药师干预口服抗肿瘤药物患者用药依从性的成效。方法采用计算机检索PubMed,Web of Science,Embase及中国知网、维普和万方医学数据库中药师对口服抗肿瘤药物患者用药依从性进行干预的相关研究,检索时限为自建库起至2022年4月1日。采用Cochrane偏倚风险评价工具RoB2进行偏倚风险评价,采用RevMan 5.4软件进行Meta分析,无法进行Meta分析的结局指标进行描述性统计。结果共纳入8项随机对照试验(RCT),涉及患者717例。常见的用药依从性干预措施为定期随访、用药教育和咨询。测量方法包括直接评估法和间接评估法,其中直接评估法通过测量血药浓度;间接评估法包括客观评估法(药片计数法和电子监测设备)和主观评估法(患者问卷调查)。4项以患者是否依从用药二分类变量为结局指标的RCT的Meta分析结果显示,药师对口服抗肿瘤药物患者进行药学干预可显著提高其用药依从性[OR=4.59,95%CI(1.09,19.29),P=0.04];亚组分析结果显示,采用主观评估法评估用药依从性的研究中,干预组的用药依从性显著提高[OR=6.84,95%CI(2.84,16.50),P<0.0001]。结论药师积极对口服抗肿瘤药物患者进行药学干预,可提高患者的用药依从性。展开更多
Pneumonia, a respiratory infection induces acute or chronic inflammation, characterized by increased activity of lymphocytes and neutrophils, thus generating oxygen-free radicals that decrease the endogenous antioxida...Pneumonia, a respiratory infection induces acute or chronic inflammation, characterized by increased activity of lymphocytes and neutrophils, thus generating oxygen-free radicals that decrease the endogenous antioxidants defence system. The aim of this experimental study focused on the capacity of nontoxic aqueous, hydroethanolic and ethanolic extracts of Greenwayodendron suaveolens (Engl. & Diels) Verdc. subsp. suaveolens to regulate free reactive species and protein inflammation generated by infectious disease. The phytochemical screenings of G. suaveolens extracts were carried out according to precipitation and colorimetric methods. The total antioxidant and flavonoid contents were determined by the Folin-Ciocalteu and Aluminium Chloride ethanolic methods. The efficiency of G. suaveolens extracts on free radicals was evaluated using DPPH<sup>•</sup>, ABTS<sup>+•</sup>, and FRAP methods. The anti-inflammatory properties of extracts were evaluated according to in vitro protein (BSA) denaturation, Proteinase Inhibitory Action, and Red Blood Cell Membrane stabilization assays. The G. suaveolens aqueous, hydroethanolic and ethanolic extracts were used for the acute toxicity assessment according to the OECD protocol. The obtained results showed the presence of flavonoids, phenols, polyphenols, tannins, anthocyanins, alkaloids, terpenoids, and sterols as secondary metabolites families in G. suaveolens extracts. The highest contents of total antioxidants and flavonoids were highlighted in the hydroethanolic extract. However, it’s the G. suaveolens aqueous extract that showed the best free radical DPPH<sup>•</sup> and ABTS<sup>+•</sup> scavenging activities (SC<sub>50</sub>) of 11.06 μg/mL and 15.16 μg/mL respectively. The highest ferric-reducing activity was found in G. suaveolens ethanolic extract with 866.23 μg EGA/mg of dry weight. The hydroethanolic extract has shown a high anti-inflammatory activity through BSA denaturation and erythrocyte membrane haemolysis with inhibitory concentrations 50 (IC<sub>50</sub>) of 48.63 and 59.22 μg/mL respectively. In contrast, proteinase inhibitory activity revealed a better potential of IC<sub>50</sub> (34.19 μg/mL) for the ethanolic extract. In oral acute toxicity, all treated groups revealed neither mortality nor any significant alteration in behaviour and locomotion. The lethal dose 50 (LD<sub>50</sub>) of G. suaveolens extracts was >5000 mg/kg. These results suggest that G. suaveolens stem-barks extracts may serve as therapeutic sources to prevent inflammation induced by oxidative stress, an important feature of infectious diseases.展开更多
文摘目的评价药师干预口服抗肿瘤药物患者用药依从性的成效。方法采用计算机检索PubMed,Web of Science,Embase及中国知网、维普和万方医学数据库中药师对口服抗肿瘤药物患者用药依从性进行干预的相关研究,检索时限为自建库起至2022年4月1日。采用Cochrane偏倚风险评价工具RoB2进行偏倚风险评价,采用RevMan 5.4软件进行Meta分析,无法进行Meta分析的结局指标进行描述性统计。结果共纳入8项随机对照试验(RCT),涉及患者717例。常见的用药依从性干预措施为定期随访、用药教育和咨询。测量方法包括直接评估法和间接评估法,其中直接评估法通过测量血药浓度;间接评估法包括客观评估法(药片计数法和电子监测设备)和主观评估法(患者问卷调查)。4项以患者是否依从用药二分类变量为结局指标的RCT的Meta分析结果显示,药师对口服抗肿瘤药物患者进行药学干预可显著提高其用药依从性[OR=4.59,95%CI(1.09,19.29),P=0.04];亚组分析结果显示,采用主观评估法评估用药依从性的研究中,干预组的用药依从性显著提高[OR=6.84,95%CI(2.84,16.50),P<0.0001]。结论药师积极对口服抗肿瘤药物患者进行药学干预,可提高患者的用药依从性。
文摘Pneumonia, a respiratory infection induces acute or chronic inflammation, characterized by increased activity of lymphocytes and neutrophils, thus generating oxygen-free radicals that decrease the endogenous antioxidants defence system. The aim of this experimental study focused on the capacity of nontoxic aqueous, hydroethanolic and ethanolic extracts of Greenwayodendron suaveolens (Engl. & Diels) Verdc. subsp. suaveolens to regulate free reactive species and protein inflammation generated by infectious disease. The phytochemical screenings of G. suaveolens extracts were carried out according to precipitation and colorimetric methods. The total antioxidant and flavonoid contents were determined by the Folin-Ciocalteu and Aluminium Chloride ethanolic methods. The efficiency of G. suaveolens extracts on free radicals was evaluated using DPPH<sup>•</sup>, ABTS<sup>+•</sup>, and FRAP methods. The anti-inflammatory properties of extracts were evaluated according to in vitro protein (BSA) denaturation, Proteinase Inhibitory Action, and Red Blood Cell Membrane stabilization assays. The G. suaveolens aqueous, hydroethanolic and ethanolic extracts were used for the acute toxicity assessment according to the OECD protocol. The obtained results showed the presence of flavonoids, phenols, polyphenols, tannins, anthocyanins, alkaloids, terpenoids, and sterols as secondary metabolites families in G. suaveolens extracts. The highest contents of total antioxidants and flavonoids were highlighted in the hydroethanolic extract. However, it’s the G. suaveolens aqueous extract that showed the best free radical DPPH<sup>•</sup> and ABTS<sup>+•</sup> scavenging activities (SC<sub>50</sub>) of 11.06 μg/mL and 15.16 μg/mL respectively. The highest ferric-reducing activity was found in G. suaveolens ethanolic extract with 866.23 μg EGA/mg of dry weight. The hydroethanolic extract has shown a high anti-inflammatory activity through BSA denaturation and erythrocyte membrane haemolysis with inhibitory concentrations 50 (IC<sub>50</sub>) of 48.63 and 59.22 μg/mL respectively. In contrast, proteinase inhibitory activity revealed a better potential of IC<sub>50</sub> (34.19 μg/mL) for the ethanolic extract. In oral acute toxicity, all treated groups revealed neither mortality nor any significant alteration in behaviour and locomotion. The lethal dose 50 (LD<sub>50</sub>) of G. suaveolens extracts was >5000 mg/kg. These results suggest that G. suaveolens stem-barks extracts may serve as therapeutic sources to prevent inflammation induced by oxidative stress, an important feature of infectious diseases.
